199 related articles for article (PubMed ID: 30320499)
21. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
22. RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis.
Wu XL; Yang ZW; He L; Dong PD; Hou MX; Meng XK; Zhao HP; Wang ZY; Wang F; Baoluri ; Wurenqimuge ; Agudamu ; Jia YF; Shi L
Oncotarget; 2017 Oct; 8(47):82968-82980. PubMed ID: 29137316
[TBL] [Abstract][Full Text] [Related]
23. Epoxy clerodane diterpene inhibits MCF-7 human breast cancer cell growth by regulating the expression of the functional apoptotic genes Cdkn2A, Rb1, mdm2 and p53.
Subash-Babu P; Alshammari GM; Ignacimuthu S; Alshatwi AA
Biomed Pharmacother; 2017 Mar; 87():388-396. PubMed ID: 28068628
[TBL] [Abstract][Full Text] [Related]
24. p53 activation in chronic radiation-treated breast cancer cells: regulation of MDM2/p14ARF.
Xia L; Paik A; Li JJ
Cancer Res; 2004 Jan; 64(1):221-8. PubMed ID: 14729628
[TBL] [Abstract][Full Text] [Related]
25. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
[TBL] [Abstract][Full Text] [Related]
26. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
Wang H; Nan L; Yu D; Agrawal S; Zhang R
Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884
[TBL] [Abstract][Full Text] [Related]
27. Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
Ou WB; Lu M; Eilers G; Li H; Ding J; Meng X; Wu Y; He Q; Sheng Q; Zhou HM; Fletcher JA
Br J Cancer; 2016 Nov; 115(10):1253-1263. PubMed ID: 27736841
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells.
Xie J; Yan Y; Liu F; Kang H; Xu F; Xiao W; Wang H; Wang Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 29769411
[TBL] [Abstract][Full Text] [Related]
29. Regulator of Ribosome Synthesis 1 (RRS1) Stabilizes GRP78 and Promotes Breast Cancer Progression.
Sun W; Song J; Wu Q; Deng L; Zhang T; Zhang L; Hua Y; Cao Y; Hou L
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474562
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
31. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
32. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis.
Akaogi K; Ono W; Hayashi Y; Kishimoto H; Yanagisawa J
BMC Cancer; 2013 Feb; 13():65. PubMed ID: 23388179
[TBL] [Abstract][Full Text] [Related]
33. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
34. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
[TBL] [Abstract][Full Text] [Related]
35. ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2.
Ma X; Fan M; Yang K; Wang Y; Hu R; Guan M; Hou Y; Ying J; Deng N; Li Q; Jiang G; Zhang Y; Zhang X
Cancer Sci; 2023 Nov; 114(11):4237-4251. PubMed ID: 37700392
[TBL] [Abstract][Full Text] [Related]
36. ICT1 knockdown inhibits breast cancer cell growth via induction of cell cycle arrest and apoptosis.
Wang C; Liang C; Feng W; Xia X; Chen F; Qiao E; Zhang X; Chen D; Ling Z; Yang H
Int J Mol Med; 2017 Apr; 39(4):1037-1045. PubMed ID: 28290601
[TBL] [Abstract][Full Text] [Related]
37. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
[TBL] [Abstract][Full Text] [Related]
39. Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.
Ma J; Xue Y; Cui W; Li Y; Zhao Q; Ye W; Zheng J; Cheng Y; Ma Y; Li S; Han T; Miao L; Yao L; Zhang J; Liu W
Cancer; 2012 Sep; 118(17):4105-16. PubMed ID: 22907703
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
